Format

Send to

Choose Destination
Int J Drug Policy. 2017 Sep;47:26-33. doi: 10.1016/j.drugpo.2017.08.001.

Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.

Author information

1
The Kirby Institute, UNSW Sydney, Sydney, Australia. Electronic address: jgrebely@kirby.unsw.edu.au.
2
CHUM Research Centre, Centre Hospitalier de l'Université de Montréal, Montréal, Canada; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada, Canada.
3
Arud Centres of Addiction Medicine, Zurich, Switzerland.
4
Department of Social and Environmental Health Research, London School of Hygiene & Tropical Medicine, London, United Kingdom.
5
School of Social & Community Medicine, University of Bristol, Bristol, United Kingdom.
6
Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.
PMID:
28888558
DOI:
10.1016/j.drugpo.2017.08.001
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for London School of Hygiene and Tropical Medicine
Loading ...
Support Center